RPRomina Pace

Romina Pace

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Romina Pace has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Kaberi Dasgupta

    Department of Medicine McGill University Montreal Quebec Canada

    11 shared publications
  • Elham Rahme

    Division of Clinical Epidemiology, Department of Medicine McGill University Montreal Quebec Canada; Centre for Outcomes Research and Evaluation (CORE) Research Institute of the McGill University Health Centre (RI-MUHC) Montreal Quebec Canada

    5 shared publications
  • Catherine Godin

    Public Health Department, Cree Board of Health and Social Services of James Bay, Chisasibi, Quebec, Canada

    2 shared publications
  • Deborah Chan

    Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

    2 shared publications
  • Deborah Da Costa

    Division of Clinical Epidemiology, Department of Medicine McGill University Montreal Quebec Canada; Centre for Outcomes Research and Evaluation (CORE) Research Institute of the McGill University Health Centre (RI-MUHC) Montreal Quebec Canada

    2 shared publications
  • Elham Rahme

    McGill University

    2 shared publications

Latest Publications

  • A Diabetes Peer Mentorship Program for First Nations Youth and Young Adults: An Intervention Protocol

    by Sahar Fazeli, Jonathan Linton, Paul Linton, Lucy Trapper, Catherine Godin, Helene Porada, Deborah Da Costa, Kaberi Dasgupta, Isabelle Malhame, Claudia Mitchell, et al.

  • Open Access

    Preventing diabetes after pregnancy with gestational diabetes in a Cree community: an inductive thematic analysis

    by Romina Pace, Orenda Loon, Deborah Chan, Helene Porada, Catherine Godin, Jonathan Linton, Paul Linton, Jill Torrie, Kaberi Dasgupta

    Introduction Historical and political factors underpin the disproportional burden of type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM) in women, a harbinger of future T2DM, in Indigenous populations. There is a need for T2DM prevention strategies driven by the voices of Indigenous women. In this study, we aimed to understand the perspectives of Cree women with prior GDM living in northern Quebec, where over a quarter of pregnancies are complicated by GDM. Research design and methods A local healthcare worker invited women with GDM in the prior 5 years to participate in semistructured interviews. A Cree-origin research partner and a researcher jointly conducted interviews in-person or by teleconference. Open-ended questions addressed GDM experience, maintaining a healthy lifestyle, and needs/preferences pertinent to designing a T2DM prevention program aimed at women affected by GDM. We adopted an inductive thematic analysis framework to categorize experiences and opinions. Results Among the 13 mothers interviewed, some success with health behavior changes during pregnancy was reported but there were difficulties postpartum resulting from time constraints, costs of healthy foods, discomfort at the gym related to not being perceived as athletic, and safety concerns. They acknowledged the existence of programs addressing T2DM prevention in their community but did not participate. They endorsed preferences for group sessions, with family collaboration and childcare, that addressed healthy cooking and physical activity and incorporated traditional elements. Conclusion Cree mothers with a history of GDM highlighted several barriers to diabetes prevention. We are working to address these barriers through the creation of a Cree-facilitator-led community-based intervention.


  • Open Access

    Closing the indigenous health gap in Canada: Results from the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) program

    by Mariam Naqshbandi Hayward, Romina Pace, Harsh Zaran, Roland Dyck, Anthony J. Hanley, Michael E. Green, Onil Bhattacharyya, Merrick Zwarenstein, Joelle Emond, Cynthia Benoit, et al.


  • Gestational diabetes mellitus and risk of incident primary cancer: A population‐based retrospective cohort study

    by Romina Pace, Elham Rahme, Kaberi Dasgupta

    Increasing evidence suggests that individuals with diabetes are at greater risk of cancer overall and specific subtypes of cancer.1 Obesity, sedentary lifestyle, hyperinsulinemia, hyperglycemia and chronic inflammation have been proposed as the pathophysiological underpinnings of these associations. 2 Similar behaviours, and physiological changes operate in women with gestational diabetes mellitus (GDM).Epidemiological studies investigating the association of GDM and malignancy have produced mixed results.


  • Open Access

    Association between gestational diabetes mellitus and depression in parents: a retrospective cohort study

    by Romina Pace, Elham Rahme, Deborah Da Costa, Kaberi Dasgupta

    Purpose: The aim of this study was to examine the association between gestational diabetes mellitus (GDM) and depression incidence in mothers and fathers during prenatal and postnatal periods. Patients and methods: Matched pairs (GDM vs no GDM) of randomly selected mothers with singleton live births (matched by age group, delivery year, and health region) and their partners (Quebec, Canada; cohort inception 1990–2007) were assessed for a composite outcome of depression/self-harm/suicide using a health administrative database. We examined the association of GDM and the composite outcome in the following three nonoverlapping periods: 1) 24 weeks gestation up to delivery; 2) delivery up to 1 year postpartum; and 3) 1 year postpartum to study end (March 31, 2012). We used stratified Cox proportional regression hazards models, with three models in mothers and three models in fathers, corresponding to each of the time periods of interest. Results: In the 58,400 mothers, women with GDM had a nearly twofold greater risk (adjusted HR: 1.82, 95% CI 1.28, 2.59) of being diagnosed with depression compared to those without GDM during the prenatal period. In the first year postpartum, there was no conclusive difference observed between the two groups of mothers (adjusted HR: 1.05, 95% CI 0.84, 1.30). Beyond the first year postpartum, there was an 8% increased risk (adjusted HR: 1.08, 95% CI 1.03, 1.14) of depression in women with a history GDM compared to those without. A total of 63,384 fathers were included in our analyses, and no association between GDM in one’s partner and depression was found during any of the three time periods evaluated. Conclusion: GDM is associated with an increased risk of depression in women particularly during pregnancy highlighting the need to screen for depression and provide supportive interventions during this period.


  • Open Access

    Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial

    by Anne-Sophie Brazeau, Sara J. Meltzer, Romina Pace, Natasha Garfield, Ariane Godbout, Leslie Meissner, Elham Rahme, Deborah Da Costa, Kaberi Dasgupta

    We recently demonstrated that a gestational diabetes history in mothers is associated with higher postpartum incident diabetes not only in mothers but also in fathers. In the present study, we examined changes in health behaviours and cardiometabolic profiles in both mothers and partners who participated in a diabetes prevention program within 5 years of a gestational diabetes pregnancy. Couples were enrolled into a 13-week program that included 5 half-day group sessions and web/telephone-based support between sessions. It was designed in consultation with patients and previously studied in mothers. We computed mean changes from baseline (95% CI) for physical activity, eating, and sleep measures, and cardiometabolic parameters (fasting and 2-h post glucose load plasma glucose, BMI, blood pressure) in both partners and mothers. Among 59 couples enrolled, 45 partners (76%) and 47 mothers (80%) completed final evaluations. Baseline cardiometabolic measures averaged within normal limits. Similar to mothers, partners increased physical activity (+ 1645 steps/day, 95%CI 730, 2561; accelerometer assessed moderate-to-vigorous physical activity + 36.4 min/week, 95% CI 1.4, 71.4) and sleep duration (+ 0.5 h/night, 95% CI 0.1, 0.9) and reduced the sodium-to-potassium ratio of food intake (− 0.09 95% CI -0.19, − 0.001). No conclusive changes were observed in glucose measures or insulin resistance; in analyses combining mothers and partners, systolic blood pressure decreased (− 2.7 mmHg, 95% CI -4.4, − 1.0). Partners and mothers demonstrated improved physical activity, sleep, and dietary quality. Baseline cardiometabolic profiles averaged at normal values and there were no changes in glucose or insulin resistance; some blood pressure impact was observed. While strategies need to be developed to attract participants at higher cardiometabolic risk, this study demonstrates that partners of women within 5 years of a gestational diabetes diagnosis can be recruited and do achieve health behaviour change. ClinicalTrials.gov: NCT02343354 (date of registration: January 22, 2015).


  • Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study

    by R. Bond, R. Pace, E. Rahme, K. Dasgupta

    To investigate whether polycystic ovary syndrome further increases postpartum diabetes risk in women with gestational diabetes mellitus and to explore relationships between polycystic ovary syndrome and incident diabetes in women who do not develop gestational diabetes. This retrospective cohort study (Quebec Physician Services Claims; Hospitalization Discharge Databases; Birth and Death registries) included 34 686 women with gestational diabetes during pregnancy (live birth), matched 1:1 to women without gestational diabetes by age group, year of delivery and health region. Diagnostic codes were used to define polycystic ovary syndrome and incident diabetes. Cox regression models were used to examine associations between polycystic ovary syndrome and incident diabetes. Polycystic ovary syndrome was present in 1.5% of women with gestational diabetes and 1.2% of women without gestational diabetes. There were more younger mothers and mothers who were not of white European ancestry among those with polycystic ovary syndrome. Those with polycystic ovary syndrome more often had a comorbidity and a lower proportion had a previous pregnancy. Polycystic ovary syndrome was associated with incident diabetes (hazard ratio 1.52; 95% CI 1.27, 1.82) among women with gestational diabetes. No conclusive associations between polycystic ovary syndrome and diabetes were identified (hazard ratio 0.94; 95% CI 0.39, 2.27) in women without gestational diabetes. In women with gestational diabetes, polycystic ovary syndrome confers additional risk for incident diabetes postpartum. In women without gestational diabetes, an association between PCOS and incident diabetes was not observed. Given the already elevated risk of diabetes in women with a history of gestational diabetes, a history of both polycystic ovary syndrome and gestational diabetes signal a critical need for diabetes surveillance and prevention.